bethechange said:
I am also in the same boat as guytim. I'm wondering whether I should pursue a different degree rather than just PharmD. What is "bench" work? Does anyone know what kind of work a drug developer would do on a daily basis? And that would require..a PhD in pharmaceutical sciences?
"Benchwork" also commonly called basic research implies working in a lab and making discoveries at that a molecular level. Clinical research often implies research via clinical trials, outcomes, epidemiology, etc. Then translational research is hypothesized to be the bridge between basic research to clinical research. There really are no true consensus statements for any of them an much of the problem is trying train researchers that can do research that will eventually benefit the masses. Unfortunately a lot of the findings in basic research are never found applicable to clinical practice or everyday life; however, w/o basic research we wouldn't have the in depth understanding of so many clinical dilemmas. Secondly, the problem isn't always realized in the lab then applied to the population as it can also occur in the opposite direction.
Example: clinical-->basic -->clinical
Reserpine administration to people for HTN also happened to lower levels of dopamine, serotonin, norepinephrine at the synapse resulting in pts committing suicide while on reserpine. Of course at that time no one was sure that a depletion in the various neurotransmitters (NTS) was leading to the increase in suicide.
At a basic level, researchers (mainly Dr. Julius Axelrod who passed last yr)were able to study the receptor at a molecular level and hypothesize that the change in mood was due to changes/decreases in NTS at the synapse. All of this ultimately led to to the development of prozac and a share of the Nobel prize in the early 70s.
Another example, but from bench-->clinical
Fleming discovering penicillin mold having an antibacterial effect. We know now where all of this led to.
My history may be a bit sketchy but hopefully the major details are correct.
Many pharmaceutical scientists in drug development will run the kinetics portions of various drug trials prior to clinical trial period and/or pharmacogenomics/polymorphisms.
Please see the following:
http://www.pharmacotherapy.org/
See this article from the the ACCP white papers and position statements on the left column, second bullet. Access should be free. Other potential position papers can be found on
www.accp.com.
Other commentary can be found at:
http://www.pitt.edu/~excelres/research_areas/trans_med.htm
General info on pharmaceutical scientists:
http://www.aapspharmaceutica.com/
or just check out various schools of pharmacy and the various programs.